1. 1169. Derivation And Validation of an International Clinical Prognostication Model for 28-day Sepsis Mortality. (15th December 2022) Authors: Blair, Paul W; Mehta, Rittal; Som, Tin; Okello, Stephen; Tsalik, Ephraim L; Wailagala, Abdullah; Woods, Christopher W; Prouty, Michael; Chenoweth, Josh; Letizia, Andrew; Faix, Dennis; Adams, Nehkonti; Ko, Emily R; Duplessis, Chris; Lamorde, Mohammed; Owusu-Ofori, Alex; Naluyima, Prossy; Kayiira, ... Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A New Era in Host Response Biomarkers to Guide Precision Medicine for Infectious Diseases. Issue 11 (14th August 2022) Authors: Ko, Emily R; Tsalik, Ephraim L Journal: Journal of the Pediatric Infectious Diseases Society Issue: Volume 11:Issue 11(2022) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Average Weighted Accuracy: Pragmatic Analysis for a Rapid Diagnostics in Categorizing Acute Lung Infections (RADICAL) Study. (3rd June 2019) Authors: Liu, Ying; Tsalik, Ephraim L; Jiang, Yunyun; Ko, Emily R; Woods, Christopher W; Henao, Ricardo; Evans, Scott R Journal: Clinical infectious diseases Issue: Volume 70:Number 12(2020) Page Start: 2736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Issue 9 (September 2022) Authors: Wolfe, Cameron R; Tomashek, Kay M; Patterson, Thomas F; Gomez, Carlos A; Marconi, Vincent C; Jain, Mamta K; Yang, Otto O; Paules, Catharine I; Palacios, Guillermo M Ruiz; Grossberg, Robert; Harkins, Michelle S; Mularski, Richard A; Erdmann, Nathaniel; Sandkovsky, Uriel; Almasri, Eyad; Pineda, Jus... Journal: Lancet Issue: Volume 10:Issue 9(2022) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparing the Diagnostic Accuracy of Clinician Judgment to a Novel Host Response Diagnostic for Acute Respiratory Illness. (10th November 2021) Authors: Jaffe, Ian S; Jaehne, Anja K; Quackenbush, Eugenia; Ko, Emily R; Rivers, Emanuel P; McClain, Micah T; Ginsburg, Geoffrey S; Woods, Christopher W; Tsalik, Ephraim L Journal: Open forum infectious diseases Issue: Volume 8:Number 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2021) Authors: Kalil, Andre C; Mehta, Aneesh K; Patterson, Thomas F; Erdmann, Nathaniel; Gomez, Carlos A; Jain, Mamta K; Wolfe, Cameron R; Ruiz-Palacios, Guillermo M; Kline, Susan; Regalado Pineda, Justino; Luetkemeyer, Anne F; Harkins, Michelle S; Jackson, Patrick E H; Iovine, Nicole M; Tapson, Victor F; Oh, M... Journal: Lancet Issue: Volume 9:Issue 12(2021) Page Start: 1365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2021) Authors: Kalil, Andre C; Mehta, Aneesh K; Patterson, Thomas F; Erdmann, Nathaniel; Gomez, Carlos A; Jain, Mamta K; Wolfe, Cameron R; Ruiz-Palacios, Guillermo M; Kline, Susan; Regalado Pineda, Justino; Luetkemeyer, Anne F; Harkins, Michelle S; Jackson, Patrick E H; Iovine, Nicole M; Tapson, Victor F; Oh, M... Journal: Lancet Issue: Volume 9:Issue 12(2021) Page Start: 1365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LB1531. Administration of Abatacept or Infliximab Reduces Mortality in Hospitalized Patients with COVID-19 Pneumonia: Results from the ACTIV-1 IM Master Protocol. (15th December 2022) Authors: Ko, Emily R Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LB1531A. Administration of abatacept, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial. (15th December 2022) Authors: Ko, Emily R; Anstrom, Kevin J; Lachiewicz, Anne; Panettieri, Reynold; Maillo, Martin; O'Halloran, Jane A; Boucher, Cynthia; Maldonado, Michael A; Chang, Soju; Bozzette, Samuel; Powderly, William G Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial. (15th December 2022) Authors: O'Halloran, Jane A; Anstrom, Kevin J; Kedar, Eyal; McCarthy, Matthew W; Ko, Emily R; Melsheimer, Richard; Boucher, Cynthia; Chang, Soju; Bozzette, Samuel; Powderly, William G Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗